Epithelial profiling of antibiotic controlled release respiratory formulations

Pharmaceutical Research

Volumn 28, Issue 9, 2011, Pages 2327-2338

  Ong, Hui Xin ^a   Traini, Daniela ^a   Bebawy, Mary ^a   Young, Paul Michael ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calu 3 air interface model; Ciprofloxacin hydrochloride; Controlled release; Dry powder inhaler; Polyvinyl alcohol

Indexed keywords

CIPROFLOXACIN; POLYVINYL ALCOHOL;

AEROSOL; ARTICLE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TOLERABILITY; EPITHELIUM CELL; IN VITRO STUDY; PERFORMANCE MEASUREMENT SYSTEM; PHYSICAL CHEMISTRY; POWDER; POWDER INHALER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AEROSOLS; ANTI-BACTERIAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DIFFUSION CHAMBERS, CULTURE; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; PARTICLE SIZE; RESPIRATORY MUCOSA; SOLUBILITY; SURFACE PROPERTIES;

EID: 80054750314     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0462-1     Document Type: Article

References (28)

1. Traini D, Young PM. Delivery of antibiotics to the respiratory tract: an update. Expert Opin Drug Deliv. 2009;6(9):897-905.
2. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr. 2007;19(1):83-8. (Pubitemid 46114762)
3. Adi H, Young PM, Chan H-K, Salama R, Traini D. Controlled release antibiotics for dry powder lung delivery. Drug Dev Ind Pharm. 2010;36(1):119-26.
4. Salama RO, Traini D, Chan H-K, Young PM. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm. 2008;70(1):145-52.
5. Widdicombe JH. Regulation of the depth and composition of airway surface liquid. J Anat. 2002;201(4):313-8. (Pubitemid 35244050)
6. Salama R, Ladd L, Chan H-K, Traini D, Young P. Development of an ovine dry powder inhalation model for the evaluation of conventional and controlled release microparticles. AAPS J. 2009;11(3):465-8.
7. Haghi M, Young PM, Traini D, Jaiswal R, Gong J, Bebawy M. Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model. Drug Dev Ind Pharm. 2010;36:1207-14.
8. Grainger CI, Greenwell LL, Lockley DJ, Martin GP, Forbes B, Grainger CI, et al. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res. 2006;23(7):1482-90. Comparative Study Research Support, Non-U. S. Gov't. (Pubitemid 43993811)
9. Bur M, Lehr CM, Bur M, Lehr C-M. Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines. Expert Opin Drug Deliv. 2008;5(6):641-52. Research Support, Non-U. S. Gov't Review. (Pubitemid 351998254)
10. Cavet M, West M, Simmons N. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells. Antimicrob Agents Chemother. 1997;41(12):2693-8. (Pubitemid 27524741)
11. Ehrhardt C, Kneuer C, Bies C, Lehr C-M, Kim K-J, Bakowsky U. Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm Pharmacol Ther. 2005;18(3):165-70. Research Support, Non-U. S. Gov't, Research Support, U. S. Gov't, P. H. S. (Pubitemid 40222110)
12. Fiegel J, Ehrhardt C, Schaefer UF, Lehr C-M, Hanes J. Large porous particle impingement on lung epithelial cell monolayers-toward improved particle characterization in the lung. Pharm Res. 2003;20(5):788-96. (Pubitemid 36515312)
13. Mathias NR, TimoszykJ, Stetsko PI, Megill JR, Smith RL, Wall DA. Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target. 2002;10(1):31-40. (Pubitemid 34223847)
14. Yan Z, Aaron C, Thomas H. Cultured human airway epithelial cells (Calu-3): a model of human respiratory function, structure, and inflammatory responses. Crit Care Res Pract. 2010;2010
15. Grainger CI, Greenwell LL, Martin GP, Forbes B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. Eur J Pharm Sci. 2009;71(2):318-24.
16. Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul. 2010;27(7):618-27.
17. Adi H, Young PM, Chan H, Stewart P, Agus H, Traini D. Cospray dried antibiotics for dry powder lung delivery. J Pharm Sci. 2007
18. Yamamoto A, Yamada K, Muramatsu H, Nishinaka A, Okumura S, Okada N, et al. Control of pulmonary absorption of watersoluble compounds by various viscous vehicles. Int J Pharm. 2004;282(1-2):141-9. (Pubitemid 39178491)
19. Salama RO, Traini D, Chan HK, Sung A, Ammit AJ, Young PM. Preparation and evaluation of controlled release microparticles for respiratory protein therapy. J Pharm Sci. 2009;98(8):2709-17.
20. Salama R, Hoe S, Chan H-K, Traini D, Young PM. Preparation and characterisation of controlled release co-spray dried drugpolymer microparticles for inhalation 1: influence of polymer concentration on physical and in vitro characteristics. Eur J Pharm Biopharm. 2008;69(2):486-95.
21. Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Investig Dermatol. 1975;64(3):190-5.
22. Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20(6):64-74. (Pubitemid 126450495)
23. Adi S, Adi H, Tang P, Traini D, Chan H-K, Young PM. Microparticle corrugation, adhesion and inhalation aerosol efficiency. Eur J Pharm Sci. 2008;35(1-2):12-8.
24. Chew NYK, Tang P, Chan H-K, Raper JA. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharm Res. 2005;22(1):148-52. (Pubitemid 40558157)
25. Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis. Pharm Res. 2010;27(1):151-60.
26. Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm. 2005;305(1-2):180-5. (Pubitemid 41568373)
27. Administration FaD. Guidance for industry; dissolution testing of immediate release solid oral dosage forms. August 1997
28. Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997;86(6):690-700. (Pubitemid 27248819)